JAK2 and metabolic dysfunction-associated steatotic liver disease: Additionally, Li et al. found that the injection of recombinant human HGF promotes the phosphorylation of JAK2-STAT3 in mouse liver and inhibits inflammation, thereby enhancing liver function in mice with non-alcoholic fatty liver disease [10].